Olivier was CEO of FTSE 100 medical devices company Smith & Nephew plc from 2011 to 2018. Prior to that, he served as CEO of healthcare, cosmetology and pharmaceutical company Laboratoires Pierre Fabre from 2010 to 2011, and from 2003 to 2010 he worked at Abbott Laboratories, rising to Corporate Executive Vice President and President of the pharmaceutical products division. Earlier in his career, Olivier worked at GlaxoSmithKline plc in positions of increasing seniority. He also served on the Board of Smiths Group plc from July 2018 to November 2020. Olivier became a Knight of the Legion of Honour in 2007. Olivier has a doctorate in Pharmacy from the University of Paris-Sud and an MBA from HEC business school in Paris.
Personal Details
Title: Dr
Surname: Buhuon
DoB: 03/01/1959
Age: 67 years
M/F: Male
Nationality: France
Country of Birth: France
Language: English
Qualification: PhD, MBA
Industry:
Qualifications & Experience
Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:
Other directorships (state)
(only entities turnover at least $5m p/a)
Company
Committee
Position
Date Appointed
Board
Member
01/01/2021
Working history
Name
President
Abbott Laboratories Appointed Date: 01/01/2003 Date Resigned: 01/01/2010 Industry: Healthcare
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.